everyone has to make their first post at some point.
I am new to the site and was enjoying reading your previous comments. As the Swiss have recently approved afamelanotide and CUV029 and CUV030 were overwhelmingly positive I was drawn to the relevance of your comment:
"However, the share price will not do much until they 1) release unequivocal good EPP results and/ or 2) there is some surprise such as another European country (such as Switzerland, the UK, Germany, etc.) follows suit with the Italians and says"
I did begin my post with the words no disrespect intended and apologise if if you feel that I have been. I am aware that it is not yourself that controls the sp.
My prediction for you is that PW will do everything he can to prevent a dilutive capital raising at anywhere near current sp. i expect some sort of JV announcement with big pharma in the upcoming months
CUV Price at posting:
$1.79 Sentiment: ST Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)